Skip to main content
SpringerLink
Log in

The public is notified by the US FDA that the dose limitation for simvastatin has been revised

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. US FDA.FDA Drug Safety Communication: Revised dose limitation for Zocor (simvastatin) when taken with amiodarone. FDA Drug Safety Newsletter: 15 Dec 2011. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The public is notified by the US FDA that the dose limitation for simvastatin has been revised. React. Wkly. 1383, 4 (2012). https://doi.org/10.2165/00128415-201213830-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00009

Keywords

Search

Navigation